Document
Academic Article
Generically Dependent Continuant
Article
Information Content Entity
RDF description of First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: The TORCH randomized trial - http://irises.unimi.it/resource/item/363490
First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: The TORCH randomized trial